Empowering patients through shared knowledge and community-driven health insights.
The information on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
© 2026 MedInfo World. All rights reserved.
Benralizumab – Uses, Side Effects, Dosage & Drug Information | MedInfo World | MedInfo World
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Home Active Ingredients Benralizumab Benralizumab Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
2 Drugs 4 Variants
Category
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
Important Notice This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Benralizumab.
Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]
RxCUI
1989104, 1989109, 2205632, 2205634, 2679499, 2679502
Drugs with Benralizumab Medications containing this ingredient
1